메뉴 건너뛰기




Volumn 152, Issue 6, 2012, Pages 984-990

BRAFV600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; DNA;

EID: 84869483749     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2012.08.039     Document Type: Article
Times cited : (57)

References (25)
  • 1
    • 68549099879 scopus 로고    scopus 로고
    • Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005
    • A.Y. Chen, A. Jemal, and E.M. Ward Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005 Cancer 115 2009 3801 3807
    • (2009) Cancer , vol.115 , pp. 3801-3807
    • Chen, A.Y.1    Jemal, A.2    Ward, E.M.3
  • 2
    • 33646442046 scopus 로고    scopus 로고
    • Increasing incidence of thyroid cancer in the United States, 1973-2002
    • L. Davies, and H.G. Welch Increasing incidence of thyroid cancer in the United States, 1973-2002 JAMA 295 2006 2164 2167
    • (2006) JAMA , vol.295 , pp. 2164-2167
    • Davies, L.1    Welch, H.G.2
  • 3
    • 64549114616 scopus 로고    scopus 로고
    • Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005
    • L. Enewold, K. Zhu, and E. Ron Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005 Cancer Epidemiol Biomarkers Prev 18 2009 784 791
    • (2009) Cancer Epidemiol Biomarkers Prev , vol.18 , pp. 784-791
    • Enewold, L.1    Zhu, K.2    Ron, E.3
  • 4
    • 0027135424 scopus 로고
    • Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989
    • discussion 7-8
    • I.D. Hay, E.J. Bergstralh, J.R. Goellner, J.R. Ebersold, and C.S. Grant Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989 Surgery 114 1993 1050 1057 discussion 7-8
    • (1993) Surgery , vol.114 , pp. 1050-1057
    • Hay, I.D.1    Bergstralh, E.J.2    Goellner, J.R.3    Ebersold, J.R.4    Grant, C.S.5
  • 5
    • 66149121888 scopus 로고    scopus 로고
    • Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer
    • R.M. Seaberg, S. Eski, and J.L. Freeman Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer Arch Otolaryngol Head Neck Surg 135 2009 355 359
    • (2009) Arch Otolaryngol Head Neck Surg , vol.135 , pp. 355-359
    • Seaberg, R.M.1    Eski, S.2    Freeman, J.L.3
  • 6
    • 84855451664 scopus 로고    scopus 로고
    • In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease
    • H. Mazeh, J. Benavidez, J.L. Poehls, L. Youngwirth, H. Chen, and R.S. Sippel In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease Thyroid 22 2012 3 8
    • (2012) Thyroid , vol.22 , pp. 3-8
    • Mazeh, H.1    Benavidez, J.2    Poehls, J.L.3    Youngwirth, L.4    Chen, H.5    Sippel, R.S.6
  • 7
    • 84865112869 scopus 로고    scopus 로고
    • Aggressive variants of papillary thyroid cancer: Incidence, characteristics and predictors of survival among 43,738 patients
    • H.S. Kazaure, S.A. Roman, and J.A. Sosa Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients Ann Surg Oncol 19 2012 1874 1880
    • (2012) Ann Surg Oncol , vol.19 , pp. 1874-1880
    • Kazaure, H.S.1    Roman, S.A.2    Sosa, J.A.3
  • 8
    • 73949133701 scopus 로고    scopus 로고
    • Papillary thyroid carcinoma with prominent hobnail features: A new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases
    • S. Asioli, L.A. Erickson, and T.J. Sebo Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases Am J Surg Pathol 34 2010 44 52
    • (2010) Am J Surg Pathol , vol.34 , pp. 44-52
    • Asioli, S.1    Erickson, L.A.2    Sebo, T.J.3
  • 9
    • 28744442816 scopus 로고    scopus 로고
    • BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer
    • M. Xing, W.H. Westra, and R.P. Tufano BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer J Clin Endocrinol Metab 90 2005 6373 6379
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 6373-6379
    • Xing, M.1    Westra, W.H.2    Tufano, R.P.3
  • 10
    • 37349131738 scopus 로고    scopus 로고
    • BRAF mutation in papillary thyroid cancer: Pathogenic role, molecular bases, and clinical implications
    • M. Xing BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications Endocr Rev 28 2007 742 762
    • (2007) Endocr Rev , vol.28 , pp. 742-762
    • Xing, M.1
  • 11
    • 53749086690 scopus 로고    scopus 로고
    • BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study
    • R. Elisei, C. Ugolini, and D. Viola BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study J Clin Endocrinol Metab 93 2008 3943 3949
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 3943-3949
    • Elisei, R.1    Ugolini, C.2    Viola, D.3
  • 12
    • 33747369828 scopus 로고    scopus 로고
    • The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma
    • T.Y. Kim, W.B. Kim, and Y.S. Rhee The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma Clin Endocrinol (Oxf) 65 2006 364 368
    • (2006) Clin Endocrinol (Oxf) , vol.65 , pp. 364-368
    • Kim, T.Y.1    Kim, W.B.2    Rhee, Y.S.3
  • 13
    • 77953766335 scopus 로고    scopus 로고
    • B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression
    • C. Nucera, A. Porrello, and Z.A. Antonello B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression Proc Natl Acad Sci U S A 107 2010 10649 10654
    • (2010) Proc Natl Acad Sci U S A , vol.107 , pp. 10649-10654
    • Nucera, C.1    Porrello, A.2    Antonello, Z.A.3
  • 14
    • 79953312648 scopus 로고    scopus 로고
    • BRAF(V600E) and microenvironment in thyroid cancer: A functional link to drive cancer progression
    • C. Nucera, J. Lawler, and S. Parangi BRAF(V600E) and microenvironment in thyroid cancer: a functional link to drive cancer progression Cancer Res 71 2011 2417 2422
    • (2011) Cancer Res , vol.71 , pp. 2417-2422
    • Nucera, C.1    Lawler, J.2    Parangi, S.3
  • 15
    • 70449370231 scopus 로고    scopus 로고
    • Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer
    • D.S. Cooper, G.M. Doherty, and B.R. Haugen Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 2009 1167 1214
    • (2009) Thyroid , vol.19 , pp. 1167-1214
    • Cooper, D.S.1    Doherty, G.M.2    Haugen, B.R.3
  • 16
    • 0031943356 scopus 로고    scopus 로고
    • Differentiated thyroid cancer: Reexamination of risk groups and outcome of treatment
    • L.E. Sanders, and B. Cady Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment Arch Surg 133 1998 419 425
    • (1998) Arch Surg , vol.133 , pp. 419-425
    • Sanders, L.E.1    Cady, B.2
  • 17
    • 79959921749 scopus 로고    scopus 로고
    • A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas
    • D. Dias-Santagata, Q. Lam, and K. Bergethon A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas Mod Pathol 24 2011 974 982
    • (2011) Mod Pathol , vol.24 , pp. 974-982
    • Dias-Santagata, D.1    Lam, Q.2    Bergethon, K.3
  • 18
    • 79954977778 scopus 로고    scopus 로고
    • Proliferative nodules arising within congenital melanocytic nevi: A histologic, immunohistochemical, and molecular analyses of 43 cases
    • P.A. Phadke, D. Rakheja, and L.P. Le Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases Am J Surg Pathol 35 2011 656 669
    • (2011) Am J Surg Pathol , vol.35 , pp. 656-669
    • Phadke, P.A.1    Rakheja, D.2    Le, L.P.3
  • 19
    • 18444374405 scopus 로고    scopus 로고
    • Mutations of the BRAF gene in human cancer
    • H. Davies, G.R. Bignell, and C. Cox Mutations of the BRAF gene in human cancer Nature 417 2002 949 954
    • (2002) Nature , vol.417 , pp. 949-954
    • Davies, H.1    Bignell, G.R.2    Cox, C.3
  • 20
    • 34250893789 scopus 로고    scopus 로고
    • Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: A meta-analysis
    • J.H. Lee, E.S. Lee, and Y.S. Kim Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis Cancer 110 2007 38 46
    • (2007) Cancer , vol.110 , pp. 38-46
    • Lee, J.H.1    Lee, E.S.2    Kim, Y.S.3
  • 21
    • 84856112428 scopus 로고    scopus 로고
    • Late intervention with anti-BRAF(V600E) therapy induces tumor regression in an orthotopic mouse model of human anaplastic thyroid cancer
    • M.A. Nehs, C. Nucera, and S.S. Nagarkatti Late intervention with anti-BRAF(V600E) therapy induces tumor regression in an orthotopic mouse model of human anaplastic thyroid cancer Endocrinology 153 2012 985 994
    • (2012) Endocrinology , vol.153 , pp. 985-994
    • Nehs, M.A.1    Nucera, C.2    Nagarkatti, S.S.3
  • 22
    • 84859551973 scopus 로고    scopus 로고
    • A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma
    • L.A. Niemeier, H.K. Akatsu, and C. Song A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma Cancer 118 2011 2069 2077
    • (2011) Cancer , vol.118 , pp. 2069-2077
    • Niemeier, L.A.1    Akatsu, H.K.2    Song, C.3
  • 23
    • 68949127354 scopus 로고    scopus 로고
    • Role of prophylactic central neck dissection in cN0 papillary thyroid cancer
    • S. Costa, G. Giugliano, and L. Santoro Role of prophylactic central neck dissection in cN0 papillary thyroid cancer Acta Otorhinolaryngol Ital 29 2009 61 69
    • (2009) Acta Otorhinolaryngol Ital , vol.29 , pp. 61-69
    • Costa, S.1    Giugliano, G.2    Santoro, L.3
  • 24
    • 33845591066 scopus 로고    scopus 로고
    • Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer
    • discussion 5-7
    • M. Sywak, L. Cornford, P. Roach, P. Stalberg, S. Sidhu, and L. Delbridge Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer Surgery 140 2006 1000 1005 discussion 5-7
    • (2006) Surgery , vol.140 , pp. 1000-1005
    • Sywak, M.1    Cornford, L.2    Roach, P.3    Stalberg, P.4    Sidhu, S.5    Delbridge, L.6
  • 25
    • 73249128367 scopus 로고    scopus 로고
    • Prophylactic central neck dissection in stage N0 papillary thyroid carcinoma
    • S. Zuniga, and A. Sanabria Prophylactic central neck dissection in stage N0 papillary thyroid carcinoma Arch Otolaryngol Head Neck Surg 135 2009 1087 1091
    • (2009) Arch Otolaryngol Head Neck Surg , vol.135 , pp. 1087-1091
    • Zuniga, S.1    Sanabria, A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.